공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 인간 마이크로바이옴 치료제 시장 기회와 전략(-2030년) : COVID-19의 성장과 변화

Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change

리서치사 The Business Research Company
발행일 2020년 12월 상품 코드 980120
페이지 정보 영문 181 Pages
가격
US $ 4,000 ₩ 4,442,000 PDF (Single User License)
US $ 6,000 ₩ 6,663,000 PDF (Site License)
US $ 8,000 ₩ 8,884,000 PDF (Enterprise License)


세계의 인간 마이크로바이옴 치료제 시장 기회와 전략(-2030년) : COVID-19의 성장과 변화 Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change
발행일 : 2020년 12월 페이지 정보 : 영문 181 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 인간 마이크로바이옴 치료제(Human Microbiome Therapeutics) 시장에 대해 조사했으며, 시장 규모와 예측, 동향과 전략, 성장 촉진요인 및 억제요인, COVID-19의 영향, 질환·시퀀싱 기술 종류·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 목차

제3장 그림목차

제4장 표목차

제5장 보고서 구조

제6장 서론

  • 지역 세분화

제7장 인간 마이크로바이옴 치료제 시장 특징

  • 시장 정의
  • 질환별 세분화
    • 감염증
    • 위장장애
    • 대사장애
    • 기타
  • 시퀀싱 기술 종류별 세분화
    • 표적 유전자
    • RNA
    • 전게놈 시퀀싱(WGS) - 샷건
    • 기타

제8장 시장 동향과 전략

  • 전략적 협업과 합의
  • 파이프라인 연구와 의약품 개발 수 증가
  • 암 마이크로바이옴 치료제 개발에 대한 투자 증가

제9장 COVID-19의 영향

제10장 시장 규모와 성장

  • 시장 매출 성장 예측(2023-2030년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제11장 시장 분석 : 지역별

  • 세계 시장 매출 예측 : 지역별(2023-2030년)
  • 세계 시장 매출 예측 : 국가별(2023-2030년)

제12장 시장 세분화

  • 세계 시장 매출 예측 : 질환별(2023-2030년)
    • 감염증
    • 위장장애
    • 대사장애
  • 세계 시장 매출 예측 : 시퀀싱 기술 종류별(2023-2030년)
    • 표적 유전자
    • RNA
    • 전게놈 샷건
    • 기타 종류

제13장 아시아태평양 시장

제14장 서유럽 시장

제15장 동유럽 시장

제16장 북미 시장

제17장 남미 시장

제18장 중동 시장

제19장 아프리카 시장

제20장 경쟁 상황

  • 기업 개요
  • Seres Therapeutics
  • Assembly Biosciences
  • Enterome Bioscience
  • Vedanta BioSciences
  • Second Genome Inc.

제21장 시장의 주요 합병과 인수

제22장 시장 기회와 전략

  • 2023년 시장 : 가장 새로운 기회를 제공하는 국가
  • 2023년 시장 : 가장 새로운 기회를 제공하는 부문
  • 2023년 시장 : 성장 전략
    • 시장 동향 기반 전략
    • 경쟁 전략

제23장 결론과 제안

  • 결론
  • 제안

제24장 부록

KSM 21.01.14

Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global human microbiome therapeutics market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the human microbiome therapeutics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global human microbiome therapeutics market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by disease, and by sequencing technology type.

Market Characteristics - The market characteristics section of the report defines and explains the human microbiome therapeutics market. This chapter also defines and describes products covered in the report.

Trends And Strategies - This chapter describes the major trends shaping the global human microbiome therapeutics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the human microbiome therapeutics market.

Global Market Size And Growth - This section contains the global forecast (2023-2025), (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the forecast periods.

Regional Analysis - This section contains the forecast (2023-2025), and (2025-2030) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2023-2030) and analysis for different segments.

Regional Market Size and Growth - This section contains the region's market size forecast (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global human microbiome therapeutics market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for human microbiome therapeutics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global human microbiome therapeutics market is segmented into -

By Disease: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases

By Sequencing Technology Type: Targeted Gene; RNA; Whole-Genome Shotgun (WGS); Others Types

Companies Mentioned: Seres Therapeutics; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc.

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Human Microbiome Therapeutics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography

7. Human Microbiome Therapeutics Market Characteristics

  • 7.1. Market Definition
  • 7.2. Segmentation By Disease
    • 7.2.1. Infectious Diseases
    • 7.2.2. Gastrointestinal Disorders
    • 7.2.3. Metabolic Disorders
    • 7.2.4. Cancers
    • 7.2.5. Other Diseases
  • 7.3. Segmentation By Sequencing Technology Type
    • 7.3.1. Targeted Gene
    • 7.3.2. RNA
    • 7.3.3. Whole-Genome Sequencing (WGS)- Shotgun
    • 7.3.4. Others Types

8. Human Microbiome Therapeutics Market Trends And Strategies

  • 8.1. Strategic Collaborations And Agreements
  • 8.2. Increasing Number Of Pipeline Studies And Drug Development
  • 8.3. Increasing Investments On Development Of Cancer Microbiome Therapeutics

9. COVID Impact Human Microbiome Therapeutics Market

10. Global Human Microbiome Therapeutics Market Size And Growth

  • 10.1. Forecast Market Growth, 2023 - 2030, Value ($ Million)
    • 10.1.1. Drivers Of The Market 2023 - 2030
    • 10.1.2. Restraints On The Market 2023 - 2030

11. Human Microbiome Therapeutics Market, Regional Analysis

  • 11.1. Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, Value ($ Million)
  • 11.2. Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, Value ($ Million)

12. Global Human Microbiome Therapeutics Market Segmentation

  • 12.1. Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
    • 12.1.1. Infectious Diseases
    • 12.1.2. Cancers
    • 12.1.3. Gastrointestinal Disorders
    • 12.1.4. Metabolic Disorders
  • 12.2. Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, Value ($ Million)
    • 12.2.1. Targeted Gene
    • 12.2.2. RNA
    • 12.2.3. Whole-genome Shotgun
    • 12.2.4. Other Type

13. Asia-Pacific Human Microbiome Therapeutics Market

  • 13.1. Asia-Pacific Human Microbiome Therapeutics Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Impact of COVID-19
    • 13.1.3. Market Information
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes Levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investment
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.3. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.4. Asia-Pacific Human Microbiome Therapeutics Market: Country Analysis
  • 13.5. China Human Microbiome Therapeutics Market
  • 13.6. China Human Microbiome Therapeutics Market Overview
    • 13.6.1. Country Information
    • 13.6.2. Impact of COVID-19
    • 13.6.3. Market Information
    • 13.6.4. Background Information
    • 13.6.5. Regulations
    • 13.6.6. Regulatory Bodies
    • 13.6.7. Major Associations
    • 13.6.8. Corporate Tax Structure
    • 13.6.9. Investment
    • 13.6.10. Major Companies
  • 13.7. China Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.8. China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.9. India Human Microbiome Therapeutics Market
  • 13.10. India Human Microbiome Therapeutics Market Overview
    • 13.10.1. Country Information
    • 13.10.2. Impact of COVID-19
    • 13.10.3. Market Information
    • 13.10.4. Background Information
    • 13.10.5. Government Initiatives
    • 13.10.6. Regulations
    • 13.10.7. Regulatory Bodies
    • 13.10.8. Major Associations
    • 13.10.9. Corporate Tax Structure
    • 13.10.10. Major Companies
  • 13.11. India Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.12. India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.13. Japan Human Microbiome Therapeutics Market
  • 13.14. Japan Human Microbiome Therapeutics Market Overview
    • 13.14.1. Country Information
    • 13.14.2. Impact of COVID-19
    • 13.14.3. Market Information
    • 13.14.4. Background Information
    • 13.14.5. Regulations
    • 13.14.6. Regulatory Bodies
    • 13.14.7. Corporate Tax Structure
    • 13.14.8. Investment
    • 13.14.9. Major Companies
  • 13.15. Japan Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.16. Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.17. Australia Human Microbiome Therapeutics Market
  • 13.18. Australia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.19. Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.20. Indonesia Human Microbiome Therapeutics Market
  • 13.21. Indonesia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.22. Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 13.23. South Korea Human Microbiome Therapeutics Market
  • 13.24. South Korea Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 13.25. South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

14. Western Europe Human Microbiome Therapeutics Market

  • 14.1. Western Europe Human Microbiome Therapeutics Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Impact Of COVID-19
    • 14.1.3. Market Information
    • 14.1.4. Background Information
    • 14.1.5. Government initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investment
    • 14.1.12. Major Companies
  • 14.2. Western Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 14.3. Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 14.4. Western Europe Human Microbiome Therapeutics Market: Country Analysis
  • 14.5. UK Human Microbiome Therapeutics Market
  • 14.6. UK Human Microbiome Therapeutics Market Overview
    • 14.6.1. Country Information
    • 14.6.2. Impact Of COVID-19
    • 14.6.3. Market Information
    • 14.6.4. Background Information
    • 14.6.5. Government Initiatives
    • 14.6.6. Regulations
    • 14.6.7. Regulatory Bodies
    • 14.6.8. Major Associations
    • 14.6.9. Taxes Levied
    • 14.6.10. Corporate Tax Structure
    • 14.6.11. Investment
    • 14.6.12. Major Companies
  • 14.7. UK Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 14.8. UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 14.9. Germany Human Microbiome Therapeutics Market
  • 14.10. Germany Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 14.11. Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 14.12. France Human Microbiome Therapeutics Market
  • 14.13. France Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 14.14. France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

15. Eastern Europe Human Microbiome Therapeutics Market

  • 15.1. Eastern Europe Human Microbiome Therapeutics Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Impact Of COVID-19
    • 15.1.3. Market Information
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes Levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 15.3. Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 15.4. Eastern Europe Human Microbiome Therapeutics Market: Country Analysis
  • 15.5. Russia Human Microbiome Therapeutics Market
  • 15.6. Russia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 15.7. Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

16. North America Human Microbiome Therapeutics Market

  • 16.1. North America Human Microbiome Therapeutics Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Impact Of COVID-19
    • 16.1.3. Market Information
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Major Associations
    • 16.1.9. Taxes Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investment
    • 16.1.12. Major Companies
  • 16.2. North America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 16.3. North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 16.4. North America Human Microbiome Therapeutics Market: Country Analysis
  • 16.5. USA Human Microbiome Therapeutics Market
  • 16.6. USA Human Microbiome Therapeutics Market Overview
    • 16.6.1. Country Information
    • 16.6.2. Impact Of COVID-19
    • 16.6.3. Market Information
    • 16.6.4. Background Information
    • 16.6.5. Government Initiatives
    • 16.6.6. Regulations
    • 16.6.7. Regulatory Bodies
    • 16.6.8. Major Associations
    • 16.6.9. Corporate Tax Structure
    • 16.6.10. Investments
    • 16.6.11. Major Companies
  • 16.7. USA Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 16.8. USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

17. South America Human Microbiome Therapeutics Market

  • 17.1. South America Human Microbiome Therapeutics Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Impact Of COVID-19
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. South America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 17.3. South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 17.4. South America Human Microbiome Therapeutics Market: Country Analysis
  • 17.5. Brazil Human Microbiome Therapeutics Market
  • 17.6. Brazil Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 17.7. Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

18. Middle East Human Microbiome Therapeutics Market

  • 18.1. Middle East Human Microbiome Therapeutics Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Impact Of COVID-19
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Middle East Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 18.3. Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

19. Africa Human Microbiome Therapeutics Market

  • 19.1. Africa Human Microbiome Therapeutics Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Impact Of COVID-19
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Taxes Levied
    • 19.1.10. Corporate Tax Structure
    • 19.1.11. Investments
    • 19.1.12. Major Companies
  • 19.2. Africa Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 19.3. Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

20. Global Human Microbiome Therapeutics Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Seres Therapeutics
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Assembly Biosciences
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Enterome Bioscience
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial Overview
  • 20.5. Vedanta BioSciences
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Second Genome Inc.
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Human Microbiome Therapeutics Market

  • 21.1. Janssen Collaborated With Kaleido Biosciences
  • 21.2. Ritter Pharmaceuticals Merged With Qualigen, Inc.
  • 21.3. Ferring Pharmaceuticals Acquired Rebiotix
  • 21.4. Monsanto Collaborated With Second Genome

22. Human Microbiome Therapeutics Market Opportunities And Strategies

  • 22.1. Global Human Microbiome Therapeutics Market In 2030 - Countries Offering Most New Opportunities
  • 22.2. Global Human Microbiome Therapeutics Market In 2030 - Segments Offering Most New Opportunities
  • 22.3. Global Human Microbiome Therapeutics Market In 2023 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Microbiome Homes Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Place
    • 23.2.3. Price
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright and Disclaimer
Back to Top
전화 문의
F A Q